<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03124277</url>
  </required_header>
  <id_info>
    <org_study_id>184_2017</org_study_id>
    <nct_id>NCT03124277</nct_id>
  </id_info>
  <brief_title>Nutritional Support for Rehabilitation In Parkinsonism</brief_title>
  <official_title>A Whey Protein-based Nutritional Supplement Enriched in Vitamin D, Leucine and Calcium for Patients With Parkinsonism Undergoing Rehabilitation Treatment: a Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emanuele Cereda</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ASST Gaetano Pini-CTO</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>U.S. Riabilitazione Parkinson, Fondazione Gaetano e Piera Borghi di Brebbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Generale Di Zona Moriggia-Pelascini</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IRCCS Policlinico S. Matteo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized, trial will tested the hypothesis that nutritional supplementation with whey
      protein, essential amino acids - mainly leucine - vitamin D and calcium would increase the
      efficacy of physical rehabilitation in old adults suffering from Parkinson's disease o
      parkinsonism
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 26, 2017</start_date>
  <completion_date type="Actual">January 17, 2018</completion_date>
  <primary_completion_date type="Actual">January 17, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional status - distance walked during the six minutes walking test</measure>
    <time_frame>30 days</time_frame>
    <description>Change in the distance walked during the six minutes walking test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional status - timed up and go test</measure>
    <time_frame>30 days</time_frame>
    <description>Change in timed up and go test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status - Berg balance scale</measure>
    <time_frame>30 days</time_frame>
    <description>Change in Berg balance scale score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status - handgrip strength</measure>
    <time_frame>30 days</time_frame>
    <description>Change in handgrip strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status - gait speed</measure>
    <time_frame>30 days</time_frame>
    <description>Change in gait speed (4 minutes walking test)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-perceived functional status</measure>
    <time_frame>30 days</time_frame>
    <description>Change in Self-assessment Parkinson's Disease Disability Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>30 days</time_frame>
    <description>Change in body weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle mass</measure>
    <time_frame>30 days</time_frame>
    <description>Change in muscle mass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>30 days</time_frame>
    <description>Occurrence of adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment continuation</measure>
    <time_frame>30 days</time_frame>
    <description>Likelihood that patients would continue taking the trial treatment as assessed by a self-rating scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Disability Physical</condition>
  <arm_group>
    <arm_group_label>Fortifit®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Best local diet + two servings (40 grams each) of powder (Fortifit®; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, 800 IU vitamin D, and a mixture of vitamins, minerals, and fibers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Best local diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fortifit®</intervention_name>
    <description>Best local diet + two servings (40 grams each) of powder (Fortifit®; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, 800 IU vitamin D, and a mixture of vitamins, minerals, and fibers.</description>
    <arm_group_label>Fortifit®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Group</intervention_name>
    <description>Best local diet</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parkinson's disease o parkinsonism

          -  admission for physical rehabilitation

          -  Informed consent

        Exclusion Criteria:

          -  Any malignant disease during the last five years

          -  Known kidney failure (previous glomerular filtration rate &lt;30 ml/min);

          -  Known liver failure (Child B or C)

          -  Psychiatric disease

          -  Endocrine disorders associated with disorders of calcium metabolism (excluding
             osteoporosis)

          -  Indications related to the study product:

        More than 10 μg (400 IU) of daily Vitamin D intake from medical sources More than 500 mg of
        daily calcium intake from medical sources. Adherence to a high energy or high protein diet
        up or use of protein containing or amino acid containing nutritional supplements up to
        three months before starting the study.

          -  Known allergy to milk, milk products or other components of the proposed interventions

          -  Indication to or ongoing artificial nutrition support

          -  Inclusion in other nutrition intervention trials

          -  Investigator's uncertainty about the willingness or ability of the subject to comply
             with the protocol requirements

          -  Refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michela Barichella, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro Parkinson, ASST Gaetano Pini-CTO di Milano</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centro Parkinson, ASST Gaetano Pini-CTO</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2017</study_first_posted>
  <last_update_submitted>February 12, 2018</last_update_submitted>
  <last_update_submitted_qc>February 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Policlinico S. Matteo</investigator_affiliation>
    <investigator_full_name>Emanuele Cereda</investigator_full_name>
    <investigator_title>Co-Project Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinsonian Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

